HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA External Relations Head Pitts To Leave Agency; CFSAN’s Bond Moves Up

This article was originally published in The Tan Sheet

Executive Summary

FDA Associate Commissioner for External Relations Peter Pitts is leaving after 14 months at the agency to join the public relations firm Manning, Selvage & Lee

You may also be interested in...



New FDA external relations head

Sheila Dearybury Walcoff is named FDA associate commissioner for exteral relations, the agency announces Sept 7. Walcoff will advise Acting Commissioner Lester Crawford, PhD, on executive-level policy and program direction for FDA's interactions and liason activities. Walcoff most recently served as a senior associate at the law firm Mayer, Brown, Rowe & Maw (Washington, D.C.). She replaces Peter Pitts, who left the position in June to pursue an opportunity in the private sector (1"The Tan Sheet" June 7, 2004, p. 8)...

FDA Staffers To Follow McClellan To CMS

Centers for Medicare & Medicaid Services Administrator Mark McClellan, MD/PhD, is bringing a team of advisors with him from FDA to CMS

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS127925

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel